S

    Scilex Holding Company (SCLX)

    Official site

    HEALTHCARE • DRUG MANUFACTURERS - GENERAL • NASDAQ

    $5.50
    +0.07 (+1.20%)

    Market Cap: $38.20M

    Last updated: Sep 01, 2026 at 10:00 AM ET

    Earnings

    Performance (10Y)

    Beat Rate
    18%(2/11)
    Avg Surprise
    -2153.28%
    PeriodReportedEst.SurpriseB/MYoY
    Jun 26
    		$-16.65N/AN/ABeat-124.4%
    Mar 26
    		$-1.17$-0.47-148.94%Miss+32.4%
    Dec 25
    		$-1.17$-0.47-149.28%Miss+50.6%
    Sep 25
    		$-21.29$-0.41-5092.68%Miss-1459.7%
    Jun 25
    		$-7.42$-0.91-715.38%Miss+19.1%
    Mar 25
    		$-1.73$-0.01-17200.00%Miss+76.5%
    Dec 24
    		$-2.37$-3.15+24.76%Beat-848.0%
    Sep 24
    		$-1.36N/A+61.00%Beat+93.8%
    Jun 24
    		$-9.17$-4.90-87.14%Miss-40.2%
    Mar 24
    		$-7.35$-3.50-110.00%Miss-3240.9%
    Dec 23
    		$-0.25$-0.23-8.70%Miss-92.3%
    Sep 23
    		$-22.05$-6.13-259.71%Miss-220400.0%
    Jun 23
    		$-6.54N/AN/ABeat-5549.7%
    Mar 23
    		$-0.22N/AN/ABeat-340.0%
    Dec 22
    		$-0.13N/AN/ABeat-285.7%
    Sep 22
    		$-0.01N/AN/ABeat+87.5%
    Jun 22
    		$0.12N/AN/ABeat+50.0%
    Mar 22
    		$-0.05N/AN/ABeat-101.9%
    Dec 21
    		$0.07N/AN/ABeat-
    Sep 21
    		$-0.08N/AN/ABeat-
    Jun 21
    		$0.08N/AN/ABeat-
    Mar 21
    		$2.70N/AN/ABeat-
    Dec 20
    		$0.00$0.00N/ABeat-
    Sep 20
    		$0.00$0.00N/ABeat-

    Key Metrics

    Valuation
    P/E Ratio-0.14EV/EBITDA-2.64x
    Price/FCFN/AFCF YieldN/A
    Profitability
    Profit Margin0.00%Operating Margin-385.00%
    ROE0.00%ROIC181.67%
    Financial Health
    Debt/Equity-0.26xInterest Coverage-17.57x
    Current Ratio0.07xQuick Ratio0.06x
    Trading Statistics
    Beta1.74Avg Volume45.52K
    52-Week High$21.3452-Week Low$2.62

    Technical Indicators Dashboard

    Moving Averages

    SMA 10$5.69
    SMA 20$6.20
    SMA 50$7.15
    SMA 200$6.64
    EMA 10$5.75
    EMA 20$6.11
    EMA 50$6.43
    EMA 200$6.58

    MACD

    Line: -0.43Signal: -0.37Hist: -0.06

    ADX

    ADX: 25.5+DI: 12.3-DI: 22.7

    Aroon & PSAR

    Aroon UpN/A
    Aroon Down100.0
    PSAR$6.37

    Bollinger Bands

    Upper Band$7.33
    Lower Band$5.07
    %B Position3641%(Upper)
    Band Width0.19

    RSI (14-Day)

    Neutral
    33.0

    Momentum Oscillators

    Stoch %K6.9
    Stoch %D7.0
    Williams %R-87.8
    ROC (10d)-14.1%
    Momentum-0.91
    CCI (20d)-108.7
    MFI (14d)24.8

    Volatility Measures

    ATR (14d)$0.53(9.6%)
    StdDev (20d)0.56
    Hist Vol54.6%(High)

    Volume Flow

    VWAP$5.43
    OBV8.1M
    AD Line15.0B
    CMF (20d)-0.177

    Volume Metrics

    Avg Vol (20d)46.2K
    Vol Ratio0.7x
    VWMA (20d)$6.13

    Pivot Points

    R3$6.17
    R2$6.01
    R1$5.72
    Pivot Point$5.56
    S1$5.27
    S2$5.11
    S3$4.82

    Advanced Oscillators

    TSI-28.14
    Ultimate Osc30.5
    KST-215.14

    Financial Data

    QuarterJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023
    Total Revenue$7.64M$8.61M$4.79M$10.56M$9.90M$5.00M$14.90M$14.44M$16.37M$10.88M$13.46M$10.12M
    Cost of Revenue$3.68M$4.45M$2.61M$3.33M$3.27M$1.38M$4.69M$3.77M$4.39M$3.84M$4.52M$3.39M
    Gross Profit$3.96M$4.17M$2.18M$7.23M$6.62M$3.62M$10.21M$10.67M$11.98M$7.04M$8.94M$6.72M
    Operating Expenses$33.39M$36.34M$113.27M$193.74M$27.13M$31.52M$38.59M$30.59M$27.60M$26.52M$27.28M$45.53M
    R&D$3.34M$3.21M$8.17M$3.90M$6.19M$2.46M$2.18M$2.35M$2.00M$3.11M$2.73M$4.07M
    SG&A$27.96M$31.03M$30.16M$188.82M$19.84M$28.06M$35.41M$29.73M$24.60M$29.28M$23.52M$40.43M
    Operating Income$-29,423,000$-32,169,000$-111,090,000$-186,512,000$-20,507,000$-27,898,000$-28,378,000$-19,917,000$-15,623,000$-19,478,000$-18,339,000$-38,805,000
    Interest Income$-50,737,000$-31,710,000$0$0$0$0$0$0$0$0$0$0
    Interest Expense$6.10M$3.78M$10.85M$2.80M$2.68M$2.48M$285,000$576,000$571,000$531,000$551,000$513,000
    Income Before Tax$-114,979,000$-45,650,000$-46,099,000$-257,819,000$-44,029,000$-26,080,000$-6,461,000$-4,388,000$-37,582,000$-24,377,000$-21,392,000$-35,529,000
    Income Tax Expense$7,000$0$0$1,000$19,000$0$0$0$0$0$8,000$0
    Net Income$-229,972,000$-45,650,000$-46,105,000$-257,820,000$-88,096,000$-26,080,000$-6,460,000$-4,388,000$-37,582,000$-24,377,000$-21,400,000$-35,529,000
    EBITDA$-54,312,000$-6,265,000$-88,014,000$-253,998,000$-40,337,000$-22,596,000$-4,950,000$-2,776,000$-35,973,000$-22,784,000$-19,776,000$-33,944,000
    EBIT$-58,138,000$-10,162,000$-90,010,000$-255,021,000$-41,347,000$-23,599,000$-6,176,000$-3,812,000$-37,011,000$-23,846,000$-20,841,000$-35,016,000
    * Some calculated fields are derived from available data when not provided by source

    Related GNG Research

    No research available

    Be the first to write about SCLX

    News

    Scilex uses Datavault AI (NASDAQ: DVLT) in $20M Vivasor credit deal

    Scilex Holding Company (NASDAQ: DVLT) has updated its Schedule 13D filing, disclosing that it now beneficially owns 17.2% of Datavault AI Inc., totaling 163,766,229 common shares. This update also reveals a new $20 million uncommitted revolving line of credit agreement with Vivasor, Inc., where Scilex transferred 50 million DVLT shares to Vivasor as a drawdown. The shares were valued at $0.3151 each on August 20, 2026.

    Stock Titan•8/24/26•
    Neutral

    Datavault AI (DVLT) insider shifts 50M shares in credit deal

    Scilex Holding Co., a major shareholder in Datavault AI Inc. (DVLT), has transferred 50 million shares of DVLT common stock to Vivasor, Inc. This transaction, valued at $0.3151 per share, was not a market sale but a drawdown under a promissory note and revolving line of credit. Following this transfer, Scilex Holding Co. directly holds 163,766,229 Datavault AI shares.

    Stock Titan•8/24/26•
    Neutral

    Federal Court Grants Motion to Stay Proceedings in Scilex v. Wade et al.

    A federal court has granted a motion to compel arbitration and stay all court proceedings in California for the case of Scilex Holding Company v. Wade et al. The court found a valid and enforceable arbitration clause in the Loan Agreement between Scilex and St. James, stipulating that Nassau, Bahamas, is the appropriate forum for dispute resolution and that there was no fraud in the execution of the agreement.

    Newswire Canada•8/20/26•
    Somewhat-Bearish

    Scilex Holding Co Q2 2026: Revenue $7.6M, Net loss $(114.7M), EPS $(16.65) — 10-Q Summary

    Scilex Holding Co (SCLX) reported a significant net loss of $(114.7M) and diluted EPS of $(16.65) for Q2 2026, on revenue of $7.6M. This represents a widening loss and a revenue decline compared to the previous year, primarily due to shipment delays of ZTlido. The company is expanding distribution and advancing its R&D pipeline despite operational challenges related to third-party manufacturing and supply chain issues.

    TradingView•8/15/26•
    Bearish

    Scilex Holding Co Q2 2026: Revenue $7.6M, Net loss $(114.7M), EPS $(16.65) — 10-Q Summary

    Scilex Holding Co reported its Q2 2026 financial results, showing revenue of $7.6 million, a net loss of $(114.7) million, and a diluted EPS of $(16.65). This represents a decrease in revenue and a widened net loss compared to Q2 2025, primarily due to shipment delays of ZTlido. The company is expanding distribution and advancing its R&D pipeline despite supply chain challenges.

    TradingView•8/14/26•
    Bearish

    Frequently Asked Questions About SCLX

    Does SCLX pay dividends?
    Scilex Holding Company (SCLX) does not currently pay a regular dividend.
    What is SCLX's market cap?
    Scilex Holding Company (SCLX) has a market capitalization of $38.20M with a current stock price of $5.50.

    Get full access to GNG Research

    Create a free account to access portfolio tracking, advanced tools, and more.

    Create Free AccountLog In